Looking for Sentiment Analysis? Discover the most popular stocks on Reddit by using our Sentiment Tracker
Market Cap 35.14M P/E - EPS this Y 26.90% Ern Qtrly Grth -
Income -116.88M Forward P/E -0.41 EPS next Y 42.30% 50D Avg Chg -39.00%
Sales - PEG - EPS past 5Y - 200D Avg Chg -41.00%
Dividend N/A Price/Book 0.21 EPS next 5Y - 52W High Chg -93.00%
Recommedations 2.00 Quick Ratio 6.61 Shares Outstanding 62.66M 52W Low Chg 93.00%
Insider Own 0.05% ROA -30.03% Shares Float 58.02M Beta 2.19
Inst Own 15.41% ROE -51.76% Shares Shorted/Prior 2.65M/4.25M Price 0.56
Gross Margin - Profit Margin - Avg. Volume 3,837,483 Target Price 6.33
Oper. Margin - Earnings Date May 8 Volume 791,819 Change -9.55%
About Tonix Pharmaceuticals Holding C

Tonix Pharmaceuticals Holding Corp., a clinical-stage biopharmaceutical company, focuses on discovering, acquiring, developing, and licensing therapeutics and diagnostics to treat and prevent human disease and alleviate suffering. Its portfolio includes immunology, rare disease, infectious disease, and central nervous system (CNS) product candidates. The company's immunology portfolio includes biologics to address organ transplant rejection, autoimmunity, and cancer, including TNX-1500, a humanized monoclonal antibody targeting CD40-ligand being developed for the prevention of allograft and xenograft rejection and for the treatment of autoimmune diseases. Its rare disease portfolio comprises TNX-2900 for the treatment of Prader-Willi syndrome. The company's infectious disease pipeline includes TNX-801, a vaccine to prevent smallpox and monkeypox; TNX-1840 and TNX-1850 that are live virus vaccines based on its recombinant pox vaccine (RPV) platform for COVID-19; TNX-3500, a small molecule antiviral drug to treat acute COVID-19; and TNX-102 SL, a small molecule drug to treat Long COVID, a chronic post-acute COVID-19 condition. Its CNS portfolio includes small molecules and biologics to treat pain, neurologic, psychiatric, and addiction conditions, including TNX-102 SL, which is in mid-Phase 3 development for the management of fibromyalgia; TNX-1900 that is in development for the prevention of migraine headache; and TNX-1300, a biologic designed to treat cocaine intoxication. The company was founded in 2007 and is headquartered in Chatham, New Jersey.

Tonix Pharmaceuticals Holding C News
06:00 AM Tonix Pharmaceuticals Announces Oral Presentation and Poster at the 5th International Congress on Controversies in Fibromyalgia
03/22/23 Tonix Pharmaceuticals to Present at the 2023 Virtual March Investor Summit
03/16/23 Tonix Pharmaceuticals Announces Presentation at the Rare Disease Innovation and Partnership Summit
03/16/23 Tonix Pharmaceuticals Initiates Enrollment in Phase 2 ‘UPLIFT’ Study of TNX-601 ER (Tianeptine Hemioxalate Extended-Release Tablets) for the Treatment of Major Depressive Disorder (MDD)
03/13/23 Tonix Pharmaceuticals Reports Fourth Quarter and Full Year 2022 Financial Results and Operational Highlights
03/07/23 Tonix Pharmaceuticals Announces Results from a Preclinical Study of Murine TNX-1700 Presented in a Poster at the Keystone Symposia, “Cancer Immunotherapy: Mechanisms of Response Versus Resistance”
02/24/23 Tonix Pharmaceuticals announces acquisition of Healion Bio antiviral portfolio
04:15 PM Tonix Pharmaceuticals Announces New Board Member, R. Newcomb Stillwell
02/22/23 Tonix Pharmaceuticals Describes Emerging Research on the Incidence of Multi-Site Pain Symptoms in Long COVID Patients During Event Titled, “Long COVID: What Will it Take to Accelerate Therapeutic Progress?”
02/16/23 Tonix Pharmaceuticals to Participate in Event Titled, “Long COVID: What Will it Take to Accelerate Therapeutic Progress?”
02/13/23 New to The Street Announces its Line-up, Four Interviews on Episode #438, Airing on the Fox Business Network, Tonight, Monday, February 13, 2023, 10:30 PM PT
02/13/23 Tonix Pharmaceuticals Announces Exclusive License of Potential Therapeutic or Preventative Fully Human and Murine Anti-SARS-CoV-2 Monoclonal Antibodies
02/10/23 New to The Street / Newsmax TV Announces its Four Corporate Interviews on Episode #437, Broadcast, Saturday, February 11, 2023, 3:30 PM ET
02/09/23 Tonix Pharmaceuticals Announces Publication of Paper in Viruses Highlighting the Company’s Development of a Vaccine to Protect Against Monkeypox and Smallpox (TNX-801)
02/06/23 Tonix Pharmaceuticals Initiates Enrollment in Phase 2 ‘PREVENTION’ Study of Potentiated Intranasal Oxytocin (TNX-1900) for the Prevention of Migraine Headaches in Chronic Migraineurs
02/03/23 Tonix Pharmaceuticals to Participate in BIO CEO & Investor Conference
02/02/23 Tonix Pharmaceuticals Seeks To Bolster Its COVID-19 Pipeline With This New Acquisition
02/02/23 Tonix Pharmaceuticals discusses exclusive license of potential monoclonal antibodies
02/02/23 Tonix Pharmaceuticals Announces Acquisition of Preclinical Infectious Disease Portfolio from Healion Bio, Inc.
02/01/23 Tonix Pharmaceuticals Announces Research Agreement with University of Maryland, Baltimore, to Study TNX-1500 (Fc-modified anti-CD40L mAb) for the Prevention of Rejection in Heart Xenograft Transplantation in Animals
TNXP Chatroom

User Image 06rich15 Posted - 1 minute ago

$TNXP mutha fkr this shit again?? Damnit just go the fuck up !

User Image ijusshtmadrorss Posted - 8 minutes ago

$TNXP 4 reverse splits in last 6 years. It’s in the past, blah blah blah. It will happen again, pre last split this is worth $.01. What a joke.

User Image RedditBaller Posted - 20 minutes ago

$TNXP hence piggies will get toasted🐷🐷✊

User Image RedditBaller Posted - 21 minutes ago

$TNXP one would want the launch pad price around 1.50 or so when results come out. When the pr is released that states resilient study positive the stock will be halted and when common folk try to buy their price will be above 1.50. Always be smarter than your feelings ✊

User Image Bigpapa1965 Posted - 41 minutes ago


User Image Schumi52 Posted - 47 minutes ago

$TNXP looks like dilution again

User Image Realtrader2425 Posted - 1 hour ago

$TNXP One reverse split left caution longs! patience! stage 2 and especially 3 is a financial bitch and the kitty will run dry patience and if u like gambling on the ”pops” she has 1-2 still left in her but not until .20’s

User Image Realtrader2425 Posted - 1 hour ago

$TNXP oh Seth! 2 decades of Millions upon Millions of dollars wasted on salary, “research”, Starbucks, and Krispy Kreme breakfast! Meetings, Symposiums, Lectures, and Research Luncheons result in your company trading at 1 penny split adjusted an absolute trainwreck but FINALLY ita coming to an end! the free money training finally stops in late 2023! this decade will be a bitch to EVER get free cash again .02-.03

User Image greg1292 Posted - 1 hour ago

$TNXP 29.50 a share I break even😳

User Image bullsheeeeeter Posted - 2 hours ago

$TNXP Seth Lederman, M.D., President and Chief Executive Officer of Tonix commented, “We are committed to building our intellectual property covering the unique properties of TNX-102 SL in multiple markets around the world. These newly issued claims strengthen and expand TNX-102 SL’s overall patent portfolio and provide Tonix with significant intellectual property protection for TNX-102 SL in the U.S."

User Image bullsheeeeeter Posted - 2 hours ago

$TNXP IF Resilient study turns out to be positive… I am very curious if they will manufacture and sell or sell to the highest bidder🧐 TNX-102SL patent is expected to provide Tonix with U.S. market exclusivity until 2035.

User Image Jamestocksdn Posted - 2 hours ago

$TNXP R/S GooooooooooooD

User Image Squidgy Posted - 2 hours ago

$TNXP Institutions must be eager to get back in on this now.

User Image ChartMill Posted - 2 hours ago

Based on estimates for the next 5 years, $TNXP will show a very strong growth in EPS: 20.20% on average per year. https://www.chartmill.com/stock/quote/TNXP/fundamental-analysis?key=9328e13b-5eec-4c22-9748-0e88c81c52d9&utm_source=stocktwits&utm_medium=FA&utm_content=TNXP&utm_campaign=social_tracking

User Image billdozer24 Posted - 2 hours ago

$TNXP Pretty clear results will come from Fibromyalgia presentation in March 31st. Why would they schedule that unless they already have the results... Of course it's going to be positive. I also love that it is in a different country.

User Image Pchander1978 Posted - 3 hours ago

$TNXP are you read.

User Image Squidgy Posted - 4 hours ago

$TNXP We are days away...

User Image stockilluminati Posted - 4 hours ago

$TNXP https://www.stockilluminati.com/tnxp/news.php - Tonix Pharmaceuticals Announces Oral Presentation and Poster at the 5th International Congress on Controversies in Fibromyalgia

User Image Maurice74 Posted - 4 hours ago

$TNXP 💪🏻

User Image bullsheeeeeter Posted - 5 hours ago

$TNXP TNX-102sl is licensed internationally 💰

User Image Schumi52 Posted - 5 hours ago

$TNXP why you would do a presentation, when you know the Phase 3 fails. I think this is exceptionally a nice PR according to a presentation

User Image oviii Posted - 5 hours ago

$TNXP haha one more shit PR news🤣🤣🤣

User Image Quantisnow Posted - 5 hours ago

$TNXP 📰 Tonix Pharmaceuticals Announces Oral Presentation and Poster at the 5th International Congress on Controversies in Fibromyalgia https://quantisnow.com/i/4238504?utm_source=stocktwits 45 seconds delayed.

User Image Newsfilter Posted - 5 hours ago

$TNXP Tonix Pharmaceuticals Announces Oral Presentation and Poster at the 5th International Congress on Controversies in Fibromyalgia https://newsfilter.io/a/0cf029143525b3c739e8002b581aaa7f

User Image Stock_Titan Posted - 5 hours ago

$TNXP Tonix Pharmaceuticals Announces Oral Presentation and Poster at the 5th International Congress on Controversies in Fibromyalgia https://www.stocktitan.net/news/TNXP/tonix-pharmaceuticals-announces-oral-presentation-and-poster-at-the-b3tz4rp4p4n4.html

User Image Kool007 Posted - 7 hours ago

$TNXP The Swiss National Bank (SIX:SNBN) raised its her rates by 50 basis points and warned that further hikes may be necessary, shrugging off risks to the financial sector and to economic growth from the collapse of Credit Suisse (SIX:CSGN) last week.

User Image risenhoover Posted - 7 hours ago

$TNXP TNXP / Tonix Pharmaceuticals Holding Corp Price Target Updated https://fintel.io/sfo/us/tnxp?utm_source=stocktwits.com&utm_medium=referral&utm_campaign=pricetarget

User Image ArcValueTrade Posted - 16 hours ago

Arc Watchlist - Today's Top Momentum Play with over 200k volume. Watching these for potentially more upside continuation. 1.7m volume $QNRX +5.9% 834k volume $TNXP +5.89% 3.4m volume $DRIP +5.6% 5.4m volume $HMY +5.6% 4.4m volume $BITI +5.59% Feel free to check out our free YouTube alerts & daily market breakdown video. YouTube link in my profile bio. Arc community is a helpful and friendly community filled with triple digit track record traders & educational content, free community room (link in bio)

User Image Thomas1969 Posted - 17 hours ago

$TNXP so what happened now so many trials and so many surprises but where is the products?

User Image RedditBaller Posted - 19 hours ago

$TNXP piggy piggy piggy piggy piggy piggy piggy piggy newb shorts🐷 playtime nearly over

Analyst Ratings
Alliance Global Partners Buy Jan 12, 23
Noble Capital Markets Outperform Apr 18, 22
Roth Capital Buy Nov 18, 19
B. Riley FBR Neutral Nov 18, 19
Roth Capital Neutral Nov 18, 19
B. Riley FBR Buy Nov 18, 19
Roth Capital Buy Nov 18, 19
Roth Capital Neutral Nov 18, 19
Cantor Fitzgerald Hold Nov 18, 19
Insider Trades Relationship Date Transactions Cost($) #Shares Value($) #Share Own SEC Form 4
LEDERMAN SETH Chief Executive Offi.. Chief Executive Officer Mar 25 Buy 0.245 100,000 24,500 112,177 03/28/22